Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inspire Medical Systems ( (INSP) ) has shared an update.
Inspire Medical Systems announced its financial results for the second quarter of 2025, reporting a revenue of $217.1 million, an 11% increase from the previous year. Despite achieving a gross margin of 84%, the company faced an operating loss of $3.3 million, partly due to a $4.0 million non-cash impairment of a strategic investment. The company also launched its Inspire V neurostimulation system in the U.S., which has received positive feedback but is experiencing slower-than-expected commercial progress, impacting financial results for the year. Executive Vice President Randall A. Ban announced his retirement effective January 30, 2026, marking the end of his influential tenure at the company.
The most recent analyst rating on (INSP) stock is a Hold with a $200.00 price target. To see the full list of analyst forecasts on Inspire Medical Systems stock, see the INSP Stock Forecast page.
Spark’s Take on INSP Stock
According to Spark, TipRanks’ AI Analyst, INSP is a Neutral.
Inspire Medical Systems shows strong financial and strategic performance with promising earnings outlook and impactful corporate events. However, technical indicators suggest bearish sentiment, and the high valuation poses potential risks. The overall score reflects these mixed factors, with financial performance and strategic initiatives being the primary strengths.
To see Spark’s full report on INSP stock, click here.
More about Inspire Medical Systems
Inspire Medical Systems is a medical technology company specializing in the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Their proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology offering a safe and effective treatment for moderate to severe obstructive sleep apnea.
Average Trading Volume: 578,934
Technical Sentiment Signal: Sell
Current Market Cap: $3.72B
Find detailed analytics on INSP stock on TipRanks’ Stock Analysis page.